Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.

about

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.

Item

http://www.wikidata.org/entity/Q40121235

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Using low-dose radiation to po ...... f a prospective phase 2 trial.

@en

type

Item

label

Using low-dose radiation to po ...... f a prospective phase 2 trial.

@en

prefLabel

Using low-dose radiation to po ...... f a prospective phase 2 trial.

@en

P1476

Using low-dose radiation to po ...... f a prospective phase 2 trial.

@en

P2093

John F Gleason

http://www.w3.org/2001/XMLSchema#string

Joseph Valentino

http://www.w3.org/2001/XMLSchema#string

Mahesh Kudrimoti

http://www.w3.org/2001/XMLSchema#string

Natalie L Silver

http://www.w3.org/2001/XMLSchema#string

Susanne M Arnold

http://www.w3.org/2001/XMLSchema#string

William F Regine

http://www.w3.org/2001/XMLSchema#string

P2860

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Low-dose hypersensitivity: current status and possible mechanisms.

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers.

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

P304

252-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADRO.2016.06.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emily Van Meter

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740895

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

5514161

http://www.w3.org/2001/XMLSchema#string